Search Results
Assessment of novel treatment options for patients with PV
Current therapy options and clinical outcomes analysis in patients with PV
The role of BMT & clinical trials in patients with PV with multiple treatment-limiting toxicities
Indication for cytoreductive therapy in ET and PV: Do we have it right?
Recent advances in the diagnosis, prognosis and survival predictions of patients with PV
Accurately assessing treatment response in PV and deciding when to switch therapies
The current treatment algorithm for polycythemia vera
What Are Treatment Options for Essential Thrombocythemia (ET) & Polycythemia Vera (PV)?
What is the unmet medical need of patients with PV and ET?
Which MPN Treatment Is Right for You? What You Need to Know
REVEAL study: long-term analysis of ruxolitinib in patients with polycythemia vera after hydroxyurea
Dr. Gaby Hobbs, MD: Diagnosis and Initial Treatment Options for ET, PV & MF
